✦ LIBER ✦

MP-04.12: Solifenacin reduces overactive bladder symptoms and improves health-related quality of life in patients previously receiving tolterodine

✍ Scribed by N. Zinner; K. Kobashi; M. Andoh; N. Smith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-04.15: Solifenacin treatment in patie

✍ S. Serels; M. Andoh; N. Smith 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Relationships between improvements in sy

✍ K. S. Coyne; V. Elinoff; D. A. Gordon; D. Y. Deng; M. Brodsky; D. B. Glasser; Z. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Relationships between symptoms, symptom

✍ R. D. Crosby; S. D. Mathias; T. S. Marshall 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

TOLTERODINE EXTENDED RELEASE (ER) FOR OV

✍ P. Van Kerrebroeck; K.S. Coyne; Z. Kopp; M. Brodsky; J.T. Wang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

TOLTERODINE EXTENDED RELEASE (TER) FOR O

✍ M. Brodsky; D.B. Glasser; K.S. Coyne; Z. Jumadilova; M. Carlsson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Correlation between improvements in over

✍ Yasue Kubota; Yoshiyuki Kojima; Yasuhiro Shibata; Makoto Imura; Kenjiro Kohri; S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB